DNA & Genetics Novo Nordisk, Vivtex Ink Up to $2.1B Deal to Develop Oral Biologics for Metabolic ConditionsBy adminFebruary 27, 20260 Credit: David Petrus Ibars / iStock / Getty Images Plus Novo Nordisk and Vivtex have announced a partnership focused on…
DNA & Genetics Lilly, Seamless Ink Up-to-$1.12B Hearing Loss CollaborationBy adminJanuary 28, 20260 Eli Lilly plans to expand its hearing loss therapy pipeline by collaborating with Seamless Therapeutics to apply the company’s next-generation…
DNA & Genetics Lilly, Nimbus Ink Up-to-$1.3B Oral Obesity Drug CollaborationBy adminJanuary 6, 20260 Researchers at work in an Eli Lilly laboratory. Lilly will partner with Nimbus Therapeutics to develop an oral treatment for…
